Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elke Neumann-Haefelin

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
BMC Cancer|November 1, 2025
Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors - a retrospective single center analysisKilian Rhein, Fruzsina Kotsis, Athina Ganner, et al.
Cancers|October 27, 2022
Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel-Lindau Disease-Results of a Prospective TrialSimon Kirste, Alexander Rühle, Stefan Zschiedrich, et al.
Cell Metabolism|May 8, 2012
TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxOStacey Robida-Stubbs, Kira Glover-Cutter, Dudley W Lamming, et al.
Clinical Neurology and Neurosurgery|November 27, 2024
Intraoperative indocyanine green (ICG) videoangiography in spinal hemangioblastoma surgery - helpful tool or unnecessary?Jan-Helge Klingler, Christine Gizaw, Bianca-Ioana Blaß, et al.
Experimental Gerontology|August 17, 2019
CBP-1/p300 acetyltransferase regulates SKN-1/Nrf cellular levels, nuclear localization, and activity in C. elegansAthina Ganner, Julia Gerber, Anna-Katharina Ziegler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2010
Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysisJochen Wilpert, Karl-Georg Fischer, Przemyslaw Pisarski, et al.
Science Advances|February 12, 2025
Nonstop mutations cause loss of renal tumor suppressor proteins <i>VHL</i> and <i>BAP1</i> and affect multiple stages of protein translationJagriti Pal, Marisa Riester, Athina Ganner, et al.
Cells|May 16, 2023
Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell CarcinomaDaniel A Mohl, Simon Lagies, Kyra Zodel, et al.
Neoplasia (New York, N.Y.)|August 3, 2025
Proteomic characterization of the pseudocapsule of clear cell renal cell carcinoma in VHL disease reveals a distinct microenvironment at the tumor boundary zoneTobias Feilen, Manuel Rogg, Grigor Andreev, et al.
Science Signaling|March 30, 2012
A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulationPiero Dalle Pezze, Annika G Sonntag, Antje Thien, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
BMC Cancer|November 1, 2025
Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors - a retrospective single center analysisKilian Rhein, Fruzsina Kotsis, Athina Ganner, et al.
Cancers|October 27, 2022
Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel-Lindau Disease-Results of a Prospective TrialSimon Kirste, Alexander Rühle, Stefan Zschiedrich, et al.
Cell Metabolism|May 8, 2012
TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxOStacey Robida-Stubbs, Kira Glover-Cutter, Dudley W Lamming, et al.
Clinical Neurology and Neurosurgery|November 27, 2024
Intraoperative indocyanine green (ICG) videoangiography in spinal hemangioblastoma surgery - helpful tool or unnecessary?Jan-Helge Klingler, Christine Gizaw, Bianca-Ioana Blaß, et al.
Experimental Gerontology|August 17, 2019
CBP-1/p300 acetyltransferase regulates SKN-1/Nrf cellular levels, nuclear localization, and activity in C. elegansAthina Ganner, Julia Gerber, Anna-Katharina Ziegler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2010
Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysisJochen Wilpert, Karl-Georg Fischer, Przemyslaw Pisarski, et al.
Science Advances|February 12, 2025
Nonstop mutations cause loss of renal tumor suppressor proteins <i>VHL</i> and <i>BAP1</i> and affect multiple stages of protein translationJagriti Pal, Marisa Riester, Athina Ganner, et al.
Cells|May 16, 2023
Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell CarcinomaDaniel A Mohl, Simon Lagies, Kyra Zodel, et al.
Neoplasia (New York, N.Y.)|August 3, 2025
Proteomic characterization of the pseudocapsule of clear cell renal cell carcinoma in VHL disease reveals a distinct microenvironment at the tumor boundary zoneTobias Feilen, Manuel Rogg, Grigor Andreev, et al.
Science Signaling|March 30, 2012
A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulationPiero Dalle Pezze, Annika G Sonntag, Antje Thien, et al.
Pageof 5